Novartis signs; Sosei passes; Amgen remunerates; J&J remunerates for RSV drug
pharma-news-for-accutar-bio-thera-nykode-heat-biologics-elusys
Accutar’s Phase I clinical tria...

FDA approves IND application of Accutar for a prostate cancer treatment trial The US Food and Drug Administ...

Benign Prostatic Hyperplasia Devices Market
Market Heats Up as Managing Benign Pr...

Benign prostatic hyperplasia, also called Benign prostatic hypertrophy or Benign prostatic obstruction, is ...

ewing-sarcoma-key-companies-and-emerging-therapies
Ewing Sarcoma: Key Companies and Emer...

Bone tumors are uncommon in adults, however, are a frequent cause of neoplastic diseases among children and...

obesity-causes-diagnosis-risk-factors-epidemiology-therapies-pipeline-treatment-therapeutics-market
The Obesity Pandemic: What can we do about it?

Obesity today is a global crisis; the number of cases is on a continuous rise. As per the WHO,  “during the years 1975 to 2016, the prevalence of overweight or obese children and adolescents ...


global-burden-of-sexually-transmitted-diseases-std
A Globally Rising Burden of Sexually Transmitted Diseases (STDs)

Caused by bacteria, viruses, and parasites, Sexually transmitted diseases (STDs) are a global health burden and it seems they are likely to maintain their status of being so in coming years also, ...


Prostate Cancer Market
Prostate Cancer Market Experiences an Influx of the Pharma Players Veering the Market Ahead

Prostate Cancer Market Size is Expected to Increase with a CAGR of 8.1% in the 7MM for the study period of 2017-30 owing to rich Pipeline, Increasing Awareness and Better Treatment Options. A m...


pharma-news
Moderna’s COVID-19 Vaccine; Quidel’s Lyra gets EUA from FDA; Neurotrope and Metuchen ...

Moderna Therapeutics has announced the positive results of trials of its COVID-19 vaccine, mRNA-1273.   The results of interim Phase I clinical trial showed promising outcomes in term...


Novartis signs; Sosei passes; Amgen remunerates; J&J remunerates for RSV drug

Novartis signs USD 2.1Billion for Endocyte acquisition Novartis has inked USD 2.1 billion agreement to takeover Endocyte. Endocyte, a biopharmaceutical company, headquartered in Indiana, licensed t...


transthyretin amyloidosis
CRISPR to cure sickle cell; FDA rejected; Stem cells use; Celgene spinoff

Rice University researchers tested CRISPR to cure sickle cell, now preparing for upcoming challenges A team of Researchers led by Rice University has recently tested CRISPR to correct the sickle ce...


Gene Therapies Whitepaper
Gene Therapies

Gene therapies are regarded as one of the potential revolution in the Pharmaceutical field and Healt.....

Toll-like Receptors Agonist
Toll-like Receptors Agoni...

Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....

Acute Myeloid Leukemia Newsletter
Acute Myeloid Leukemia...

Acute myeloid leukemia (AML), also called acute myelogenous leukemia and acute nonlymphocytic leukem.....

Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?

Burn is a global public health problem, causing more than 180,000 deaths per year acros...

NexoBrid and its Awaiting US Approval

A Burn takes place when the skin comes into contact with a heat source. Burns can occur...

New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...

Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...

Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...

Emerging Market for Organ on a Chip

The organ on a chip is a microfluidic culture device that recapitulates the complicated...